Neuroprotective role of lactate after cerebral ischemia.


Autoria(s): Berthet C.; Lei H.; Thevenet J.; Gruetter R.; Magistretti P.J.; Hirt L.
Data(s)

2009

Resumo

It is well established that lactate can be used as an energy substrate by the brain by conversion to pyruvate and a subsequent oxidation in the mitochondria. Knowing the need for readily metabolizable substrates directly after ischemia and the protective effect of lactate after excitotoxicity, the aim of this study was to investigate whether lactate administration directly after ischemia could be neuroprotective. In vitro, the addition of 4 mmol/L L-lactate to the medium of rat organotypic hippocampal slices, directly after oxygen and glucose deprivation (OGD), protected against neuronal death, whereas a higher dose of 20 mmol/L was toxic. In vivo, after middle cerebral artery occlusion in the mouse, an intracerebroventricular injection of 2 microL of 100 mmol/L L-lactate, immediately after reperfusion, led to a significant decrease in lesion size, which was more pronounced in the striatum, and an improvement in neurologic outcome. A later injection 1 h after reperfusion did not reduce lesion size, but significantly improved neurologic outcome, which is an important point in the context of a potential clinical application. Therefore, a moderate increase in lactate after ischemia may be a therapeutic tool.

Identificador

http://serval.unil.ch/?id=serval:BIB_35DC3E05F74D

isbn:1559-7016[electronic], 0271-678X[linking]

pmid:19675565

doi:10.1038/jcbfm.2009.97

isiid:000271429500006

Idioma(s)

en

Fonte

Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 11, pp. 1780-1789

Palavras-Chave #Animals; Brain Ischemia/pathology; Brain Ischemia/physiopathology; Brain Lactate; Cell Death/drug effects; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Substrate; Hippocampus/drug effects; Hippocampus/pathology; Inbred Strains; Injections, Intraventricular; In-Vitro; Lactic Acid/administration & dosage; Lactic Acid/pharmacology; L-Lactate; Magnetic Resonance Spectroscopy; Magnetic-Resonance-Spectroscopy; Male; Mice; Mice, Inbred ICR; Middle Cerebral Artery Occlusion; Mouse-Brain; Neurochemical Profile; Neuroprotective Agents/administration & dosage; Neuroprotective Agents/pharmacology; Oxygen And Glucose Deprivation; Periinfarct Depolarizations; Rat; Rats; Synaptic Function; Vivo H-1-Nmr Spectroscopy
Tipo

info:eu-repo/semantics/article

article